CIGB-300, a synthetic peptide-based drug that targets the...

Molecular and Cellular Biochemistry 2011 / 10 Vol. 356; Iss. 1-2

CIGB-300, a synthetic peptide-based drug that targets the CK2 phosphoaceptor domain. Translational and clinical research

Silvio E. Perea, Idania Baladron, Yanelda Garcia, Yasser Perera, Adlin Lopez, Jorge L. Soriano, Noyde Batista, Aley Palau, Ignacio Hernández, Hernán Farina, Idrian Garcia, Lidia Gonzalez, Jeovanis Gil
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
356
Language:
english
Pages:
6
DOI:
10.1007/s11010-011-0950-y
Date:
October, 2011
File:
PDF, 310 KB
english, 2011
Conversion to is in progress
Conversion to is failed